{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:28:12Z","timestamp":1790659692511,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":757,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1111\/apt.12431","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T07:58:46Z","timestamp":1375689526000},"page":"563-572","source":"Crossref","is-referenced-by-count":78,"title":["Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy"],"prefix":"10.1111","volume":"38","author":[{"given":"A.","family":"Agarwal","sequence":"first","affiliation":[{"name":"IBD Services & Education; Department of Gastroenterology and Hepatology; School of Medicine; University of Adelaide at Royal Adelaide Hospital; Adelaide; SA; Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Andrews","sequence":"additional","affiliation":[{"name":"IBD Services & Education; Department of Gastroenterology and Hepatology; School of Medicine; University of Adelaide at Royal Adelaide Hospital; Adelaide; SA; Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"10.1111\/apt.12431-BIB0001|apt12431-cit-0001","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gut.37.4.585","article-title":"\u2018Sticky\u2019 neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis","volume":"37","author":"Dwarakanath","year":"1995","journal-title":"Gut"},{"key":"10.1111\/apt.12431-BIB0002|apt12431-cit-0002","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apt.12431-BIB0003|apt12431-cit-0003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","article-title":"Pyoderma gangrenosum","volume":"351","author":"Callen","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/apt.12431-BIB0004|apt12431-cit-0004","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0005|apt12431-cit-0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00128071-200708020-00002","article-title":"The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease","volume":"8","author":"Reguiai","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/apt.12431-BIB0006|apt12431-cit-0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10350-004-0944-x","article-title":"Management of peristomal pyoderma gangrenosum","volume":"48","author":"Kiran","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/apt.12431-BIB0007|apt12431-cit-0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D39C8094S3","article-title":"Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab","volume":"18","author":"Ueda","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1111\/apt.12431-BIB0008|apt12431-cit-0008","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-4632.2008.03412.x","article-title":"Pyoderma gangrenosum-rebel without a cure?","volume":"47","author":"Jacob","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/apt.12431-BIB0009|apt12431-cit-0009","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/apt.12431-BIB0010|apt12431-cit-0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1346-8138.2011.01346.x","article-title":"Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease","volume":"39","author":"Hayashi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1111\/apt.12431-BIB0011|apt12431-cit-0011","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1346-8138.2011.01212.x","article-title":"Superficial granulomatous pyoderma accompanied with ulcerative colitis successfully treated with tacrolimus ointment","volume":"38","author":"Tao","year":"2011","journal-title":"J Dermatol"},{"key":"10.1111\/apt.12431-BIB0012|apt12431-cit-0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.crohns.2010.10.006","article-title":"Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services\u2019 Adult Hospital 1998-2009","volume":"5","author":"Polcz","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1111\/apt.12431-BIB0013|apt12431-cit-0013","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1346-8138.2010.01009.x","article-title":"Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease","volume":"38","author":"Hanafusa","year":"2011","journal-title":"J Dermatol"},{"key":"10.1111\/apt.12431-BIB0014|apt12431-cit-0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1529-8019.2010.01357.x","article-title":"Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report","volume":"23","author":"Baglieri","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1111\/apt.12431-BIB0015|apt12431-cit-0015","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.331.7528.1323","article-title":"Pyoderma gangrenosum in ulcerative colitis: considerations for an early diagnosis","volume":"331","author":"Papageorgiou","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/apt.12431-BIB0016|apt12431-cit-0016","first-page":"e397","article-title":"Scrotal pyoderma gangrenosum associated with Crohn's disease","volume":"50","author":"Ho","year":"2009","journal-title":"Singapore Med J"},{"key":"10.1111\/apt.12431-BIB0017|apt12431-cit-0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00296-009-1168-0","article-title":"Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature","volume":"31","author":"Goldshmid","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1111\/apt.12431-BIB0018|apt12431-cit-0018","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ibd.20748","article-title":"Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease","volume":"15","author":"Alkhouri","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0019|apt12431-cit-0019","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/j.1572-0241.2007.01528_8.x","article-title":"Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis","volume":"102","author":"Castro-Fernandez","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0020|apt12431-cit-0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2230.2009.03413.x","article-title":"Beclometasone inhaler used to treat pyoderma gangrenosum","volume":"35","author":"Chriba","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/apt.12431-BIB0021|apt12431-cit-0021","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1590\/S0037-86822008000600020","article-title":"Pyoderma gangrenosum and ulcerative colitis in the tropics","volume":"41","author":"Alese","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1111\/apt.12431-BIB0022|apt12431-cit-0022","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2007.08202.x","article-title":"Pyoderma gangrenosum and interleukin 8","volume":"157","author":"Oka","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/apt.12431-BIB0023|apt12431-cit-0023","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2230.2006.02093.x","article-title":"Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease","volume":"31","author":"Akay","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/apt.12431-BIB0024|apt12431-cit-0024","first-page":"251","article-title":"Pyoderma gangrenosum","volume":"62","author":"Tan","year":"2007","journal-title":"Med J Malaysia"},{"key":"10.1111\/apt.12431-BIB0025|apt12431-cit-0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.reuma.2011.07.003","article-title":"Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab","volume":"8","author":"Carrasco Cubero","year":"2012","journal-title":"Reumatol Clin"},{"key":"10.1111\/apt.12431-BIB0026|apt12431-cit-0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000108637","article-title":"Simultaneous onset of ulcerative colitis and disseminated pyoderma gangrenosum","volume":"1","author":"Neesse","year":"2007","journal-title":"Case Rep Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0027|apt12431-cit-0027","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ibd.20081","article-title":"Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab","volume":"13","author":"Morena","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0028|apt12431-cit-0028","first-page":"401","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report","volume":"14","author":"Kouklakis","year":"2005","journal-title":"Rom J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0029|apt12431-cit-0029","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5021\/ad.2010.22.4.422","article-title":"A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine","volume":"22","author":"Lee","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1111\/apt.12431-BIB0030|apt12431-cit-0030","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1002\/ibd.21784","article-title":"Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum","volume":"17","author":"Franco","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0031|apt12431-cit-0031","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ibd.21684","article-title":"Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene","volume":"17","author":"Lin","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0032|apt12431-cit-0032","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.3748\/wjg.14.5471","article-title":"Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: rapid disappearance with methylprednisolone","volume":"14","author":"Aseni","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0033|apt12431-cit-0033","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/ibd.20481","article-title":"Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis","volume":"14","author":"Ermis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0034|apt12431-cit-0034","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ibd.20327","article-title":"Recombinant human epidermal growth factor enhances wound healing of pyoderma gangrenosum in a patient with ulcerative colitis","volume":"14","author":"Kim","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0035|apt12431-cit-0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000106584","article-title":"Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review","volume":"215","author":"Juillerat","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/apt.12431-BIB0036|apt12431-cit-0036","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ibd.20181","article-title":"Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases","volume":"13","author":"Cocco","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0037|apt12431-cit-0037","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00054725-200407000-00014","article-title":"Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis","volume":"10","author":"Baumgart","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0038|apt12431-cit-0038","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1365-2133.2004.06249.x","article-title":"Leukocytapheresis treatment for pyoderma gangrenosum","volume":"151","author":"Fujimoto","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/apt.12431-BIB0039|apt12431-cit-0039","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/j.1572-0241.2008.02094_14.x","article-title":"Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis","volume":"103","author":"Fernandez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0040|apt12431-cit-0040","first-page":"702","article-title":"Rapid improvement of pyoderma gangrenosum after treatment with infliximab","volume":"9","author":"Chan","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/apt.12431-BIB0041|apt12431-cit-0041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/09546630310019364","article-title":"Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream","volume":"15","author":"Patel","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/apt.12431-BIB0042|apt12431-cit-0042","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00296-004-0467-8","article-title":"The effect of infliximab on extraintestinal manifestations of Crohn's disease","volume":"25","author":"Kaufman","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1111\/apt.12431-BIB0043|apt12431-cit-0043","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1023\/B:DDAS.0000042245.20042.4f","article-title":"Treatment of pyoderma gangrenosum with infliximab in Crohn's disease","volume":"49","author":"Sapienza","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12431-BIB0044|apt12431-cit-0044","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archderm.140.12.1427","article-title":"Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum","volume":"140","author":"Daniels","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/apt.12431-BIB0045|apt12431-cit-0045","first-page":"56","article-title":"Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases","volume":"56","author":"Altieri","year":"2010","journal-title":"Ostomy Wound Manage"},{"key":"10.1111\/apt.12431-BIB0046|apt12431-cit-0046","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archdermatol.2009.57","article-title":"Mycophenolate mofetil as therapy for pyoderma gangrenosum","volume":"145","author":"Eaton","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/apt.12431-BIB0047|apt12431-cit-0047","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1744-9987.2007.00424.x","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum","volume":"11","author":"Seishima","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1111\/apt.12431-BIB0048|apt12431-cit-0048","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1463-1318.2004.00607.x","article-title":"Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases","volume":"6","author":"Khurrum","year":"2004","journal-title":"Colorectal Dis"},{"key":"10.1111\/apt.12431-BIB0049|apt12431-cit-0049","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00042737-200410000-00017","article-title":"Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis","volume":"16","author":"Abdelrazeq","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12431-BIB0050|apt12431-cit-0050","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3748\/wjg.15.2293","article-title":"Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone","volume":"15","author":"Zold","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.12431-BIB0051|apt12431-cit-0051","first-page":"e8","article-title":"Adalimumab therapy for recalcitrant pyoderma gangrenosum","volume":"5","author":"Fonder","year":"2006","journal-title":"J Burns Wounds"},{"key":"10.1111\/apt.12431-BIB0052|apt12431-cit-0052","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3315\/jdcr.2009.1027","article-title":"Development of pyoderma gangrenosum during therapy with infliximab","volume":"3","author":"Jaimes-Lopez","year":"2009","journal-title":"J Dermatol Case Rep"},{"key":"10.1111\/apt.12431-BIB0053|apt12431-cit-0053","doi-asserted-by":"crossref","first-page":"E1594","DOI":"10.1002\/ibd.21915","article-title":"Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin","volume":"18","author":"Sinagra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0054|apt12431-cit-0054","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1440-0960.2007.00344.x","article-title":"Use of infliximab in pyoderma gangrenosum","volume":"48","author":"Hewitt","year":"2007","journal-title":"Australas J Dermatol"},{"key":"10.1111\/apt.12431-BIB0055|apt12431-cit-0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.MIB.0000172558.39767.b7","article-title":"Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report","volume":"11","author":"Yanaru-Fujisawa","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12431-BIB0056|apt12431-cit-0056","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1111\/apt.12431-BIB0057|apt12431-cit-0057","first-page":"173","article-title":"Pyoderma gangrenosum: a review of 86 patients","volume":"55","author":"Powell","year":"1985","journal-title":"Q J Med"},{"key":"10.1111\/apt.12431-BIB0058|apt12431-cit-0058","first-page":"88","article-title":"Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"6","author":"Menachem","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1111\/apt.12431-BIB0059|apt12431-cit-0059","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.135.5.564","article-title":"Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management","volume":"135","author":"Sheldon","year":"2000","journal-title":"Arch Surg"},{"key":"10.1111\/apt.12431-BIB0060|apt12431-cit-0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine (Baltimore)"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12431","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.12431\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T18:47:27Z","timestamp":1646246847000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.12431","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,5]]}}}